Works matching AU Chiarion-Sileni, Vanna

Results: 62
    1

    Efficacy and safety of ipilimumab in patients with advanced melanoma and brain metastases.

    Published in:
    Journal of Neuro-Oncology, 2014, v. 118, n. 1, p. 109, doi. 10.1007/s11060-014-1400-y
    By:
    • Queirolo, Paola;
    • Spagnolo, Francesco;
    • Ascierto, Paolo;
    • Simeone, Ester;
    • Marchetti, Paolo;
    • Scoppola, Alessandro;
    • Vecchio, Michele;
    • Guardo, Lorenza;
    • Maio, Michele;
    • Giacomo, Anna;
    • Antonuzzo, Andrea;
    • Cognetti, Francesco;
    • Ferraresi, Virginia;
    • Ridolfi, Laura;
    • Guidoboni, Massimo;
    • Guida, Michele;
    • Pigozzo, Jacopo;
    • Chiarion Sileni, Vanna
    Publication type:
    Article
    2
    3

    Adjuvant Pembrolizumab in Stage II Melanoma: Outcomes by Primary Tumor Location in the Randomized, Double-Blind, Phase III KEYNOTE-716 Trial: KEYNOTE-716 Outcomes by Tumor Location: C. H. Yoon et al.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2025, v. 32, n. 4, p. 2756, doi. 10.1245/s10434-024-16642-6
    By:
    • Yoon, Charles H.;
    • Ross, Merrick I.;
    • Gastman, Brian R.;
    • Luke, Jason J.;
    • Ascierto, Paolo A.;
    • Long, Georgina V.;
    • Rutkowski, Piotr;
    • Khattak, Muhammad;
    • Del Vecchio, Michele;
    • de la Cruz Merino, Luis;
    • Mackiewicz, Jacek;
    • Chiarion-Sileni, Vanna;
    • Schadendorf, Dirk;
    • Carlino, Matteo S.;
    • Zhao, Yujie;
    • Fukunaga-Kalabis, Mizuho;
    • Krepler, Clemens;
    • Eggermont, Alexander M. M.;
    • Gershenwald, Jeffrey E.;
    • Sondak, Vernon K.
    Publication type:
    Article
    4
    5

    Cutaneous melanoma in adolescents and young adults.

    Published in:
    Journal of the European Academy of Dermatology & Venereology, 2024, v. 38, n. 10, p. 1997, doi. 10.1111/jdv.20077
    By:
    • Buja, Alessandra;
    • Rugge, Massimo;
    • Trevisiol, Chiara;
    • Zanovello, Anna;
    • Brazzale, Alessandra Rosalba;
    • Zorzi, Manuel;
    • Vecchiato, Antonella;
    • Del Fiore, Paolo;
    • Tropea, Saveria;
    • Chiarion‐Sileni, Vanna;
    • Rossi, Carlo Riccardo;
    • Mocellin, Simone
    Publication type:
    Article
    6
    7

    Squamous cell carcinoma antigen 1 is associated to poor prognosis in esophageal cancer through immune surveillance impairment and reduced chemosensitivity.

    Published in:
    Cancer Science, 2019, v. 110, n. 5, p. 1552, doi. 10.1111/cas.13986
    By:
    • Turato, Cristian;
    • Scarpa, Melania;
    • Kotsafti, Andromachi;
    • Cappon, Andrea;
    • Quarta, Santina;
    • Biasiolo, Alessandra;
    • Cavallin, Francesco;
    • Trevellin, Elisabetta;
    • Guzzardo, Vincenza;
    • Fassan, Matteo;
    • Chiarion‐Sileni, Vanna;
    • Castoro, Carlo;
    • Rugge, Massimo;
    • Vettor, Roberto;
    • Scarpa, Marco;
    • Pontisso, Patrizia
    Publication type:
    Article
    8

    PD‐L1 expression, CD8+ and CD4+ lymphocyte rate are predictive of pathological complete response after neoadjuvant chemoradiotherapy for squamous cell cancer of the thoracic esophagus.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 13, p. 6036, doi. 10.1002/cam4.2359
    By:
    • Fassan, Matteo;
    • Cavallin, Francesco;
    • Guzzardo, Vincenza;
    • Kotsafti, Andromachi;
    • Scarpa, Melania;
    • Cagol, Matteo;
    • Chiarion‐Sileni, Vanna;
    • Maria Saadeh, Luca;
    • Alfieri, Rita;
    • Castagliuolo, Ignazio;
    • Rugge, Massimo;
    • Castoro, Carlo;
    • Scarpa, Marco
    Publication type:
    Article
    9

    Corrigendum: Melanoma in Adolescents and Young Adults (AYA): Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.

    Published in:
    2021
    By:
    • Del Fiore, Paolo;
    • Russo, Irene;
    • Ferrazzi, Beatrice;
    • Monico, Alessandro Dal;
    • Cavallin, Francesco;
    • Filoni, Angela;
    • Tropea, Saveria;
    • Russano, Francesco;
    • Di Prata, Claudia;
    • Buja, Alessandra;
    • Collodetto, Alessandra;
    • Spina, Romina;
    • Carraro, Sabrina;
    • Cappellesso, Rocco;
    • Nicolè, Lorenzo;
    • Chiarion-Sileni, Vanna;
    • Pigozzo, Jacopo;
    • Dall'Olmo, Luigi;
    • Rastrelli, Marco;
    • Vecchiato, Antonella
    Publication type:
    Correction Notice
    10
    11

    Melanoma in Adolescents and Young Adults: Evaluation of the Characteristics, Treatment Strategies, and Prognostic Factors in a Monocentric Retrospective Study.

    Published in:
    Frontiers in Oncology, 2021, v. 11, p. 1, doi. 10.3389/fonc.2021.725523
    By:
    • Del Fiore, Paolo;
    • Russo, Irene;
    • Ferrazzi, Beatrice;
    • Monico, Alessandro Dal;
    • Cavallin, Francesco;
    • Filoni, Angela;
    • Tropea, Saveria;
    • Russano, Francesco;
    • Di Prata, Claudia;
    • Buja, Alessandra;
    • Collodetto, Alessandra;
    • Spina, Romina;
    • Carraro, Sabrina;
    • Cappellesso, Rocco;
    • Nicolè, Lorenzo;
    • Chiarion-Sileni, Vanna;
    • Pigozzo, Jacopo;
    • Dall'Olmo, Luigi;
    • Rastrelli, Marco;
    • Vecchiato, Antonella
    Publication type:
    Article
    12

    Sex-related differences in serum biomarker levels predict the activity and efficacy of immune checkpoint inhibitors in advanced melanoma and non-small cell lung cancer patients.

    Published in:
    Journal of Translational Medicine, 2024, v. 22, n. 1, p. 1, doi. 10.1186/s12967-024-04920-6
    By:
    • Pasello, Giulia;
    • Fabricio, Aline S. C.;
    • Del Bianco, Paola;
    • Salizzato, Valentina;
    • Favaretto, Adolfo;
    • Piccin, Luisa;
    • Zustovich, Fable;
    • Fabozzi, Alessio;
    • De Rossi, Costanza;
    • Pigozzo, Jacopo;
    • De Nuzzo, Mattia;
    • Cappelletto, Elia;
    • Bonanno, Laura;
    • Palleschi, Dario;
    • De Salvo, Gian Luca;
    • Guarneri, Valentina;
    • Gion, Massimo;
    • Chiarion-Sileni, Vanna
    Publication type:
    Article
    13

    Per- and polyfluoroalkyl substances (PFAS) exposure in melanoma patients: a retrospective study on prognosis and histological features.

    Published in:
    Environmental Health: A Global Access Science Source, 2022, v. 21, n. 1, p. 1, doi. 10.1186/s12940-022-00944-x
    By:
    • Del Fiore, Paolo;
    • Cavallin, Francesco;
    • Mazza, Marcodomenico;
    • Benna, Clara;
    • Monico, Alessandro Dal;
    • Tadiotto, Giulia;
    • Russo, Irene;
    • Ferrazzi, Beatrice;
    • Tropea, Saveria;
    • Buja, Alessandra;
    • Cozzolino, Claudia;
    • Cappellesso, Rocco;
    • Nicolè, Lorenzo;
    • Piccin, Luisa;
    • Pigozzo, Jacopo;
    • Chiarion-Sileni, Vanna;
    • Vecchiato, Antonella;
    • Menin, Chiara;
    • Bassetto, Franco;
    • Tos, Angelo Paolo Dei
    Publication type:
    Article
    14
    15
    16

    Surgical Treatment of Melanoma: A Survey of Italian Hospitals.

    Published in:
    Dermatology (10188665), 2013, v. 226, p. 28, doi. 10.1159/000348873
    By:
    • Testori, Alessandro;
    • Chiarion-Sileni, Vanna;
    • Stanganelli, Ignazio;
    • Rossi, Carlo Riccardo;
    • Di Filippo, Franco;
    • Ridolfi, Ruggero;
    • Parmiani, Giorgio;
    • Gandini, Sara;
    • Soteldo, Javier
    Publication type:
    Article
    17

    Diagnostic Services for Melanoma in Italy.

    Published in:
    Dermatology (10188665), 2013, v. 226, p. 3, doi. 10.1159/000348860
    By:
    • Stanganelli, Ignazio;
    • Ascierto, Paolo;
    • Bono, Riccardo;
    • De Giorgi, Vincenzo;
    • Pimpinelli, Nicola;
    • Chiarion-Sileni, Vanna;
    • Palmieri, Giuseppe;
    • Pizzichetta, Maria Antonietta;
    • Testori, Alessandro
    Publication type:
    Article
    18

    Surgical Management of Suspicious Melanocytic Lesions in Italy.

    Published in:
    Dermatology (10188665), 2013, v. 226, p. 18, doi. 10.1159/000348864
    By:
    • De Giorgi, Vincenzo;
    • Ascierto, Paolo;
    • Bono, Riccardo;
    • Pimpinelli, Nicola;
    • Chiarion-Sileni, Vanna;
    • Palmieri, Giuseppe;
    • Pizzichetta, Maria Antonietta;
    • Testori, Alessandro;
    • Stanganelli, Ignazio
    Publication type:
    Article
    19
    20

    Impact of Mole Mapping in the Italian Health System.

    Published in:
    Dermatology (10188665), 2013, v. 226, p. 13, doi. 10.1159/000348863
    By:
    • Stanganelli, Ignazio;
    • Ascierto, Paolo;
    • Bono, Riccardo;
    • De Giorgi, Vincenzo;
    • Pimpinelli, Nicola;
    • Chiarion-Sileni, Vanna;
    • Palmieri, Giuseppe;
    • Pizzichetta, Maria Antonietta;
    • Testori, Alessandro
    Publication type:
    Article
    21
    22

    Follow-Up of Melanoma: A Survey of Italian Hospitals.

    Published in:
    Dermatology (10188665), 2013, v. 226, p. 32, doi. 10.1159/000348874
    By:
    • Testori, Alessandro;
    • Chiarion-Sileni, Vanna;
    • Stanganelli, Ignazio;
    • Rossi, Carlo Riccardo;
    • Di Filippo, Franco;
    • Ridolfi, Ruggero;
    • Parmiani, Giorgio;
    • Gandini, Sara;
    • Soteldo, Javier
    Publication type:
    Article
    23

    Altitude Effect on Cutaneous Melanoma Epidemiology in the Veneto Region (Northern Italy): A Pilot Study.

    Published in:
    Life (2075-1729), 2022, v. 12, n. 5, p. 745, doi. 10.3390/life12050745
    By:
    • Del Fiore, Paolo;
    • Russo, Irene;
    • Dal Monico, Alessandro;
    • Tartaglia, Jacopo;
    • Ferrazzi, Beatrice;
    • Mazza, Marcodomenico;
    • Cavallin, Francesco;
    • Tropea, Saveria;
    • Buja, Alessandra;
    • Cappellesso, Rocco;
    • Nicolè, Lorenzo;
    • Chiarion-Sileni, Vanna;
    • Menin, Chiara;
    • Vecchiato, Antonella;
    • Dei Tos, Angelo Paolo;
    • Alaibac, Mauro;
    • Mocellin, Simone
    Publication type:
    Article
    24

    Retrospective Chart Review of Dabrafenib Plus Trametinib in Patients with Metastatic BRAF V600-Mutant Melanoma Treated in the Individual Patient Program (DESCRIBE Italy).

    Published in:
    Targeted Oncology, 2021, v. 16, n. 6, p. 789, doi. 10.1007/s11523-021-00850-1
    By:
    • Aglietta, Massimo;
    • Chiarion-Sileni, Vanna;
    • Fava, Paolo;
    • Guidoboni, Massimo;
    • Depenni, Roberta;
    • Minisini, Alessandro;
    • Consoli, Francesca;
    • Ascierto, Paolo;
    • Rinaldi, Gaetana;
    • Banzi, Maria;
    • Marconcini, Riccardo;
    • Gueli, Rossana;
    • Ferraresi, Virginia;
    • Tucci, Marco;
    • Tonini, Giuseppe;
    • Lo Re, Giovanni;
    • Guida, Michele;
    • Del Vecchio, Michele;
    • Marcon, Ilaria Gioia;
    • Queirolo, Paola
    Publication type:
    Article
    25
    26

    TRK Protein Expression in Merkel Cell Carcinoma Is Not Caused by NTRK Fusions.

    Published in:
    International Journal of Molecular Sciences, 2022, v. 23, n. 23, p. 15366, doi. 10.3390/ijms232315366
    By:
    • Cappellesso, Rocco;
    • Nicolè, Lorenzo;
    • Del Fiore, Paolo;
    • Barzon, Luisa;
    • Sinigaglia, Alessandro;
    • Riccetti, Silvia;
    • Franco, Renato;
    • Zito Marino, Federica;
    • Munari, Giada;
    • Zamuner, Carolina;
    • Cavallin, Francesco;
    • Sbaraglia, Marta;
    • Galuppini, Francesca;
    • Bassetto, Franco;
    • Alaibac, Mauro;
    • Chiarion-Sileni, Vanna;
    • Piccin, Luisa;
    • Benna, Clara;
    • Fassan, Matteo;
    • Mocellin, Simone
    Publication type:
    Article
    27
    28
    29

    Cytokine and soluble programmed death-ligand 1 levels in serum and plasma of cancer patients treated with immunotherapy: Preanalytical and analytical considerations.

    Published in:
    International Journal of Biological Markers, 2024, v. 39, n. 1, p. 9, doi. 10.1177/03936155231226234
    By:
    • Cappelletto, Elia;
    • Fasiolo, Laura Tiozzo;
    • Salizzato, Valentina;
    • Piccin, Luisa;
    • Fabozzi, Alessio;
    • Contato, Anna;
    • Bianco, Paola Del;
    • Pasello, Giulia;
    • Chiarion-Sileni, Vanna;
    • Gion, Massimo;
    • Fabricio, Aline S. C.
    Publication type:
    Article
    30
    31
    32
    33

    Cisplatin, etoposide, and ifosfamide in non-small cell lung carcinoma. A phase II randomized study with cisplatin and etoposide as the control arm.

    Published in:
    1990
    By:
    • Paccagnella, Adriano;
    • Favaretto, Adolfo;
    • Brandes, Alba;
    • Ghiotto, Cristina;
    • Fornasiero, Driano;
    • Volpi, Antonio;
    • Pappagallo, Giovanni;
    • Festi, Giuliana;
    • Cipriani, Angiolo;
    • Vinante, Orazio;
    • Chiarion-Sileni, Vanna;
    • Fiorentino, Mario V.;
    • Paccagnella, A;
    • Favaretto, A;
    • Brandes, A;
    • Ghiotto, C;
    • Fornasiero, A;
    • Volpi, A;
    • Pappagallo, G;
    • Festi, G
    Publication type:
    journal article
    34

    Effects of cyclophosphamide and IL-2 on regulatory CD4 T cell frequency and function in melanoma patients vaccinated with HLA-class I peptides: impact on the antigen-specific T cell response.

    Published in:
    Cancer Immunology, Immunotherapy, 2013, v. 62, n. 5, p. 897, doi. 10.1007/s00262-013-1397-7
    By:
    • Camisaschi, Chiara;
    • Filipazzi, Paola;
    • Tazzari, Marcella;
    • Casati, Chiara;
    • Beretta, Valeria;
    • Pilla, Lorenzo;
    • Patuzzo, Roberto;
    • Maurichi, Andrea;
    • Cova, Agata;
    • Maio, Michele;
    • Chiarion-Sileni, Vanna;
    • Tragni, Gabrina;
    • Santinami, Mario;
    • Vergani, Barbara;
    • Villa, Antonello;
    • Berti, Emilio;
    • Umansky, Ludmila;
    • Beckhove, Philipp;
    • Umansky, Viktor;
    • Parmiani, Giorgio
    Publication type:
    Article
    35

    Ipilimumab in pretreated patients with metastatic uveal melanoma: safety and clinical efficacy.

    Published in:
    Cancer Immunology, Immunotherapy, 2012, v. 61, n. 1, p. 41, doi. 10.1007/s00262-011-1089-0
    By:
    • Danielli, Riccardo;
    • Ridolfi, Ruggero;
    • Chiarion-Sileni, Vanna;
    • Queirolo, Paola;
    • Testori, Alessandro;
    • Plummer, Ruth;
    • Boitano, Monica;
    • Calabrò, Luana;
    • Rossi, Costanza;
    • Giacomo, Anna;
    • Ferrucci, Pier;
    • Ridolfi, Laura;
    • Altomonte, Maresa;
    • Miracco, Clelia;
    • Balestrazzi, Angelo;
    • Maio, Michele
    Publication type:
    Article
    36

    Characteristics of Real-World Patients with High-Risk BRAF<sup>V600E/K</sup>-Mutated Melanoma Receiving Adjuvant Treatment with Dabrafenib Plus Trametinib After Surgical Resection, Through the Italian Managed Access Program.

    Published in:
    Cancer Management & Research, 2023, v. 15, p. 1271, doi. 10.2147/CMAR.S423970
    By:
    • Quaglino, Pietro;
    • Ascierto, Paolo A;
    • Consoli, Francesca;
    • Queirolo, Paola;
    • Spagnolo, Francesco;
    • Morelli, Maria Francesca;
    • Berardi, Rossana;
    • Chiarion-Sileni, Vanna;
    • Tucci, Marco;
    • Troiani, Teresa;
    • Melotti, Barbara;
    • Rossi, Ernesto;
    • Mandala, Mario;
    • Rinaldi, Gaetana;
    • Marcon, Ilaria Gioia;
    • Pizzuti, Matteo;
    • Del Vecchio, Michele
    Publication type:
    Article
    37

    The immune cell landscape of metastatic uveal melanoma correlates with overall survival.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2021, v. 40, n. 1, p. 1, doi. 10.1186/s13046-021-01947-1
    By:
    • Tosi, Anna;
    • Cappellesso, Rocco;
    • Dei Tos, Angelo Paolo;
    • Rossi, Valentina;
    • Aliberti, Camillo;
    • Pigozzo, Jacopo;
    • Fabozzi, Alessio;
    • Sbaraglia, Marta;
    • Blandamura, Stella;
    • Del Bianco, Paola;
    • Chiarion-Sileni, Vanna;
    • Rosato, Antonio
    Publication type:
    Article
    38
    39

    Association Between Baseline Disease Characteristics and Relapse-Free Survival (RFS) in Patients (pts) with BRAF V600--Mutant Resected Stage III Melanoma Treated with Adjuvant Dabrafenib (D) + Trametinib (T) or Placebo (PBO).

    Published in:
    Journal of Oncology Navigation & Survivorship, 2019, v. 10, n. 11, p. 500
    By:
    • Schadendorf, Dirk;
    • Dummer, Reinhard;
    • Hauschild, Axel;
    • Santinami, Mario;
    • Atkinson, Victoria;
    • Mandalà, Mario;
    • Chiarion-Sileni, Vanna;
    • Larkin, James;
    • Nyakas, Marta;
    • Dutriaux, Caroline;
    • Haydon, Andrew;
    • Mortier, Laurent;
    • Robert, Caroline;
    • Schachter, Jacob;
    • Ortmann, Christine-Elke;
    • de Jong, Egbert;
    • Gasal, Eduard;
    • Kefford, Richard;
    • Kirkwood, John M.;
    • Long, Georgina V.
    Publication type:
    Article
    40

    Pembrolizumab for the First-Line Treatment of Recurrent Locally Advanced or Metastatic Merkel Cell Carcinoma: Results from the Single-Arm, Open-Label, Phase III KEYNOTE-913 Study.

    Published in:
    American Journal of Clinical Dermatology, 2024, v. 25, n. 6, p. 987, doi. 10.1007/s40257-024-00885-w
    By:
    • Mortier, Laurent;
    • Villabona, Lisa;
    • Lawrence, Ben;
    • Arance, Ana;
    • Butler, Marcus O.;
    • Beylot-Barry, Marie;
    • Saiag, Philippe;
    • Samimi, Mahtab;
    • Ascierto, Paolo A.;
    • Spada, Francesca;
    • De Pontville, Michel;
    • Maio, Michele;
    • Berrocal, Alfonso;
    • Espinosa, Enrique;
    • Capdevila, Jaume;
    • Levin, Max;
    • Das, Debasmita;
    • Krepler, Clemens;
    • Grebennik, Dmitri;
    • Chiarion-Sileni, Vanna
    Publication type:
    Article
    41

    Adjuvant Use of Pembrolizumab for Stage III Melanoma in a Real-World Setting in Europe.

    Published in:
    Cancers, 2024, v. 16, n. 21, p. 3558, doi. 10.3390/cancers16213558
    By:
    • Weichenthal, Michael;
    • Mangana, Joanna;
    • Gavrilova, Iva;
    • Lugowska, Iwona;
    • Shalamanova, Gergana Krumova;
    • Kandolf, Lidija;
    • Chiarion-Sileni, Vanna;
    • Mohr, Peter;
    • Karanikolova, Teodora Sotirova;
    • Teterycz, Pawel;
    • Espinosa, Enrique;
    • Schnecko, Philipp;
    • Cheng, Phil;
    • Bender, Marc;
    • Jiang, Shan;
    • Burke, Thomas;
    • Ascierto, Paolo Antonio;
    • Gogas, Helen;
    • Rodas, Ivan Marquez;
    • Rutkowski, Piotr
    Publication type:
    Article
    42

    The Pattern of Progression to First-Line Treatment with Dabrafenib and Trametinib in Patients with Unresectable or Metastatic, BRAF-Mutated, Cutaneous Melanoma: Results of the Observational T-WIN Study.

    Published in:
    Cancers, 2023, v. 15, n. 7, p. 1980, doi. 10.3390/cancers15071980
    By:
    • Del Vecchio, Michele;
    • Chiarion Sileni, Vanna;
    • Quaglino, Pietro;
    • Rinaldi, Gaetana;
    • Minisini, Alessandro;
    • Troiani, Teresa;
    • Consoli, Francesca;
    • Sponghini, Andrea;
    • Banzi, Maria;
    • Morelli, Maria Francesca;
    • Palleschi, Dario;
    • Rossi, Ernesto;
    • Marconcini, Riccardo;
    • Depenni, Roberta;
    • Carnevale-Schianca, Fabrizio;
    • Marcon, Ilaria;
    • Queirolo, Paola
    Publication type:
    Article
    43
    44
    45

    Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programme.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2013, v. 32, n. 1, p. 1, doi. 10.1186/1756-9966-32-82
    By:
    • Altomonte, Maresa;
    • Di Giacomo, Anna Maria;
    • Queirolo, Paola;
    • Ascierto, Paolo Antonio;
    • Spagnolo, Francesco;
    • Bajetta, Emilio;
    • Calabrò, Luana;
    • Danielli, Riccardo;
    • de Rosa, Francesco;
    • Maur, Michela;
    • Chiarion-Sileni, Vanna;
    • Francesco Ferrucci, Pier;
    • Giannarelli, Diana;
    • Testori, Alessandro;
    • Ridolfi, Ruggero;
    • Maio, Michele
    Publication type:
    Article
    46

    The cost of unresectable stage III or stage IV melanoma in Italy.

    Published in:
    Journal of Experimental & Clinical Cancer Research (17569966), 2012, v. 31, n. 1, p. 91, doi. 10.1186/1756-9966-31-91
    By:
    • Maio, Michele;
    • Ascierto, Paolo;
    • Testori, Alessandro;
    • Ridolfi, Ruggero;
    • Bajetta, Emilio;
    • Queirolo, Paola;
    • Guida, Michele;
    • Romanini, Antonella;
    • Chiarion-Sileni, Vanna;
    • Pigozzo, Jacopo;
    • Di Giacomo, Anna Maria;
    • Calandriello, Mario;
    • Didoni, Guido;
    • van Baardewijk, Marck;
    • Konto, Cyril;
    • Lucioni, Carlo
    Publication type:
    Article
    47
    48

    Tolerability of intensified intravenous interferon alfa-2b versus the ECOG 1684 schedule as adjuvant therapy for stage III melanoma: a randomized phase III Italian Melanoma Inter-group trial (IMI -- Mel.A.) [ISRCTN75125874].

    Published in:
    BMC Cancer, 2006, v. 6, p. 44, doi. 10.1186/1471-2407-6-44
    By:
    • Chiarion-Sileni, Vanna;
    • Del Bianco, Paola;
    • Romanini, Antonella;
    • Guida, Michele;
    • Paccagnella, Adriano;
    • Palma, Maurizio Dalla;
    • Naglieri, Emanuele;
    • Ridolfi, Ruggero;
    • Silvestri, Barbara;
    • Michiara, Maria;
    • De Salvo, Gian Luca
    Publication type:
    Article
    49

    Avelumab expanded access program in metastatic Merkel cell carcinoma: Efficacy and safety findings from patients in Europe and the Middle East.

    Published in:
    International Journal of Cancer, 2021, v. 149, n. 11, p. 1926, doi. 10.1002/ijc.33746
    By:
    • Ascierto, Paolo Antonio;
    • Orlova, Kristina;
    • Grignani, Giovanni;
    • Dudzisz‐Śledź, Monika;
    • Fenig, Eyal;
    • Chiarion Sileni, Vanna;
    • Fazio, Nicola;
    • Samimi, Mahtab;
    • Mortier, Laurent;
    • Gebhardt, Christoffer;
    • Kramkimel, Nora;
    • Steven, Neil;
    • Bechter, Oliver;
    • Arance, Ana;
    • Benincasa, Elena;
    • Kostkova, Lenka;
    • Costa, Nuno;
    • Lorigan, Paul
    Publication type:
    Article
    50

    TNF-Based Isolated Limb Perfusion Followed by Consolidation Biotherapy with Systemic Low-dose Interferon Alpha 2b in Patients with In-transit Melanoma Metastases: A Pilot Trial.

    Published in:
    Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 4, p. 1218, doi. 10.1245/s10434-007-9791-z
    By:
    • Rossi, Carlo;
    • Russano, Francesco;
    • Mocellin, Simone;
    • Chiarion-Sileni, Vanna;
    • Foletto, Mirto;
    • Pilati, Pierluigi;
    • Campana, Luca;
    • Zanon, Antonio;
    • Picchi, Gian;
    • Lise, Mario;
    • Nitti, Donato
    Publication type:
    Article